How Will the Biologics Contract Development Market Grow? Key Trends and Opportunities for 2025 and Beyond
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the biologics contract development market grown over the years?
The market size of biologics contract development has experienced a significant surge over the past few years. An increase from $7.75 billion in 2024 to $8.58 billion in 2025 with a compound annual growth rate (CAGR) of 10.6% is projected. This growth during the historical period is due to factors such as the growth of the biologics market, increase in biopharmaceuticals, complexity of biologics, patent expirations, and cost efficiency.
What Is the forecasted market size and growth rate for the biologics contract development market?
It is anticipated that the biologics contract development market will experience swift expansion in the coming years. With a compound annual growth rate of 11.4%, its value is anticipated to reach $13.19 billion in 2029. This projected expansion during the forecast period can be ascribed to factors such as data analytics and digitalization, risk management, scalability and adaptability, escalating R&D investments along with the growth of precision medicine and individualized therapies. The forthcoming trends within this period are expected to involve regenerative medicine, risk reduction techniques, international partnerships, breakthrough technologies, and technological integration.
Get your biologics contract development market report here!
What are the major factors driving growth in the biologics contract development market?
The escalating instances of chronic illnesses are projected to drive the growth of the biologics contract development market in the future. Chronic diseases are long-lasting ailments requiring continuous medical care. The escalating cases of such diseases are stepping up the demand for the creation of new drugs, including biologics, thereby stimulating the biologics contract development market. For example, evidence from a report issued by the Office for Health Improvement & Disparities, a government body in the UK, showed that in the first half of 2023, chronic lower respiratory diseases were responsible for an additional 3,940 deaths, a rise of 30% more than anticipated rates. Throughout the whole of that year, the death toll escalated to 5,363, showing an overall increment of 22%. Consequently, the increasing incidences of chronic diseases are expected to fuel the biologics contract development market’s expansion.
What key areas define the segmentation of the global biologics contract development Market?
The biologics contract development market covered in this report is segmented –
1) By Source: Microbial, Mammalian, Others Sources
2) By Indication: Oncology, Immunological Disorders, Cardiovascular Disorders, Hematological Disorders, Others Indications
3) By Product Service: Cell Line Development, Process Development, Others Product Services
Subsegments:
1) By Microbial: Bacterial Sources, Yeast Sources, Fungal Sources
2) By Mammalian: Chinese Hamster Ovary (CHO) Cells, Human Embryonic Kidney (HEK) Cells, Hybridoma Cells
3) By Other Sources: Plant-Based Systems, Insect Cell Systems, Algal Sources
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8219&type=smp
What are the top market players propelling the growth of the biologics contract development industry?
Major companies operating in the biologics contract development market are WuXi Biologics, Abzena Ltd., Fujifilm Diosynth Biotechnologies, KBI Biopharma, AGC Biologics, Thermo Fisher Scientific Inc, LakePharma Inc., GenScript Biotech Corporation, Bionova Scientific Inc., Boehringer Ingelheim GmbH, STC Biologics, Siegfried Evionnaz SA, BioAgilytix Labs Inc., Samsung BioLogics, Forge Biologics, Lonza Group, Catalent Inc., AbbVie Inc., Cytovance Biologics, Emergent BioSolutions, Eurofins CDMO, Meridian Life Science Inc., Merck Group, Patheon N.V., ProBioGen AG, Rentschler Biopharma SE, Sartorius AG, Syngene International Limited, Vibalogics GmbH, Yposkesi
What are the key trends shaping the future of the biologics contract development market?
The biologics contract development market is witnessing an increasing trend of technological advancements. To maintain their market standing, key firms in this industry are incorporating state-of-the-art technologies. For example, in January 2022, a Swiss company providing contract manufacturing and development solutions named Lonza, introduced the bYlok technology platform. This platform, used for designing and producing bispecific antibodies, offers a solution to the problem of light-heavy chain mispairing and provides high yields with more than 95% precision while retaining a mAb-like format. Pharma and biotech corporations can utilize this technology via a straightforward research license.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8219
What regions are dominating the biologics contract development market growth?
North America was the largest region in the biologics contract development market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biologics contract development market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Chemicals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report
Agricultural Implement Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/agricultural-implement-global-market-report
Genetically Modified Crops Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/genetically-modified-crops-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
